NCT07364396 Efficacy and Safety of CRC01 in Participants With Severe, Refractory Systemic Lupus Erythematosus Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07260877 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus Status RECRUITING Phase PHASE2
NCT07203404 A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. Status RECRUITING Phase EARLY_PHASE1
NCT07149402 Association of Serum Interleukin-33 Levels With Clinical Manifestations in Systemic Lupus Erythematosus Status NOT_YET_RECRUITING Phase N/A
NCT07148115 Pregnancies Before the Diagnosis of Systemic Lupus Erythematosus Status RECRUITING Phase N/A
NCT07069348 SLE Severity Linked to Vitamin D Via Treg Cells in Pediatric Patients Status COMPLETED Phase N/A
NCT06872086 Assessment of Blood Indices in Systemic Lupus Erythematosus Status NOT_YET_RECRUITING Phase N/A
NCT06839976 CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus Status RECRUITING Phase PHASE1/PHASE2
NCT06775912 Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases Status RECRUITING Phase EARLY_PHASE1
NCT06763783 Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases Status ENROLLING_BY_INVITATION Phase PHASE4
NCT06737380 UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients Status RECRUITING Phase PHASE1
NCT06613360 A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus Status RECRUITING Phase PHASE1
NCT06581029 Evaluating Mental Health Challenges in Juvenile Lupus Erythematosus and Their Caregivers Status NOT_YET_RECRUITING Phase N/A
NCT06548620 A Study of RD06-04 in Patients With Active Autoimmune Diseases Status WITHDRAWN Phase EARLY_PHASE1
NCT06265220 AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06182969 A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus. Status RECRUITING Phase PHASE1/PHASE2
NCT05966480 Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05958446 Fetal-Hope Study: Home Monitoring of Fetal Heart Rate in SSA+ Pregnant Women Status RECRUITING Phase N/A